Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EG.5.1.14NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.7.9ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.7.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.7.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.7.9NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KW.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KW.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KW.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KW.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
MF.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
MF.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
MF.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
MF.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LF.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LF.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LF.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LF.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KR.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KR.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KR.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KR.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.7.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.7.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.7.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
JN.1.7.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.2.3.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.2.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.2.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.2.3.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KR.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KR.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KR.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
KR.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.49ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.49ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.49ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
JN.1.49NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
MF.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
MF.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
MF.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
MF.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.192ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.192ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.192ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.192NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.39.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.39.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.39.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.39.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
ME.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used